Month: September 2025

PURCHASE, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study has reached the 75% enrollment mark. The START Study is enrolling approximately 540 individuals with mild cognitive impairment (MCI) and early Alzheimer’s disease who will be treated with zervimesine (CT1812) or placebo for 18 months. Cognition is conducting the study in collaboration with the Alzheimer’s Clinical Trials Consortium (ACTC) with funding from the National Institute of Aging (NIA) at the National Institutes of Health. “We believe the strong enrollment pace in the START Study is due to interest on the part of patients and investigators in the potential of a convenient, once-daily...

PALO ALTO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company will host an investor webinar on Wednesday, September 10, 2025 at 8:00 am ET with Rachel Gafni, M.D., Senior Research Physician at the National Institute of Dental and Craniofacial Research, part of the National Institutes of Health (NIH) and Principal Investigator and Steering Committee Co-Chair for CALIBRATE, the Company’s Phase 3 clinical trial for autosomal dominant hypocalcemia type 1 (ADH1). Dr. Gafni will provide an overview of ADH1, specifically focusing on pathophysiology, the current unmet need, and the rationale for evaluating encaleret as a treatment for ADH1. In addition to Dr. Gafni, executive members...

Multi-year BSS platform support renewal strengthens Digitel’s ability to scale, innovate and deliver 5G-powered customer experiences TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Digitel, a leading mobile network operator in Venezuela, has extended its partnership with Optiva, signing a multi-year services renewal agreement, reinforcing its commitment to innovation and rapid growth. The renewal empowers Digitel to further leverage Optiva’s full-stack BSS platform, including charging, billing and provisioning, enabling Digitel to accelerate time to market and expand its product portfolio with the confidence of continued platform reliability and stability. Digitel serves more than 7.2 million subscribers and recently became the first operator to offer 5G technology to the Venezuelan market. Since 2014, its collaboration with Optiva...

Showcases strong technology partnerships with Kongsberg Geospatial and MatrixSpace, positioning Volatus as the integrator of a proven ecosystem. Strengthens Volatus’ competitive position as one of the few Canadian operators authorized at this advanced level. Enhances Volatus’ commercialized drone-in-a-box and advanced BVLOS applications by introducing a scalable light weight detect and avoid systems. Expands Volatus’ BVLOS portfolio into higher-value missions unlocks recurring revenue opportunities in drone-in-a-box, logistics, and enterprise monitoring.TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Volatus Aerospace Inc. (TSXV: FLT, OTCQB: TAKOF, FSE: ABB.F) (“Volatus” or “the Company”), a leader in aerial solutions, today announced that Transport Canada has issued a Special Flight Operations Certificate (SFOC) authorizing Volatus...

EMERYVILLE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad Sitko, will present a company update at the H.C. Wainwright 27th Annual Global Investment Conference. Mr. Hughes and Mr. Sitko will present on Monday, September 8, 2025 at 9:00 AM ET.  The webcast for the presentation can be accessed by visiting https://bit.ly/4mjFgkY.  XOMA Royalty’s presentation can be also accessed by visiting the investor relations section of the Company’s website at www.xoma.com. About XOMA Royalty CorporationXOMA Royalty is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health.  XOMA Royalty acquires the potential...

Achieved durable production of serum AAT protein at levels associated with a lower risk of AATD liver and lung diseases following repeat 200 mg doses of WVE-006 (11.9 µM total AAT, 7.2 µM M-AAT)  First-ever demonstration of therapeutically restored physiological serum AAT production in a Pi*ZZ individual during a non-drug related acute phase response (20.6 µM total AAT, 10.3 µM M-AAT) Single dose of 400 mg achieved 12.8 µM total AAT and 5.3 µM M-AAT; ongoing 400 mg multidose cohort has potential to deliver further increases in serum AAT Data from 200 mg and 400 mg cohorts support monthly or less frequent subcutaneous dosing; 400 mg monthly multidose cohort data expected in 1Q 2026 WVE-006 continues to be well tolerated with a favorable safety profile to date Wave to host investor conference call and webcast at 8:30 a.m. ET today CAMBRIDGE,...

BRECKENRIDGE, Colo., Sept. 03, 2025 (GLOBE NEWSWIRE) — Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), has announced a strategic change in its California distribution approach, appointing Winebow, a respected national partner, to manage distribution responsibilities within the state. Winebow, a trusted leader in nationwide beverage distribution, is now overseeing Breckenridge Distillery’s full spirits collection across California—including its celebrated bourbon whiskey, whiskey, rum, vodka, gin, and newly launched tequila. Winebow’s strong presence on the West Coast and dedication to exceptional service make them the perfect partner to help Breckenridge Distillery thrive and reach even more fans throughout the Golden State. “This collaboration...

TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) today announced the completion of its early works program at its cobalt refinery north of Toronto. This milestone strengthens Electra’s readiness to restart full construction and shortens the ramp-up time required for mobilizing a full construction crew, reaffirming the Company’s commitment to onshoring North America’s critical minerals processing and building a resilient, domestic battery materials supply chain. The early works program focused on several targeted site-level activities designed to prepare for the restart of full-scale construction. The initiative, supported by strategic government funding, focused primarily on advancing the solvent extraction (SX) facility, a key step in producing...

SMITHFIELD, Va., Sept. 03, 2025 (GLOBE NEWSWIRE) — Smithfield Foods, Inc. (Nasdaq: SFD) (the “Company”), an American food company and an industry leader in value-added packaged meats and fresh pork, today announced the launch of a secondary public offering of 16,000,000 shares of common stock of the Company to be sold by SFDS UK Holdings Limited, the principal shareholder of the Company. In addition, the selling shareholder intends to grant the underwriters a 30-day option to purchase up to 2,400,000 additional shares of the Company’s common stock at the public offering price, less underwriting discounts and commissions. The Company is not selling any shares of common stock in the offering and will not receive any proceeds from the sale of the shares by the selling shareholder, including from any exercise by the underwriters of...